MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 23, 2005; DOI: 10.1124/mol.105.015438


0026-895X/05/6805-1475-1483$20.00
Mol Pharmacol 68:1475-1483, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.015438v1
68/5/1475    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rayes, D.
Right arrow Articles by Bouzat, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rayes, D.
Right arrow Articles by Bouzat, C.

Single-Channel Kinetic Analysis of Chimeric {alpha}7–5HT3A Receptors

Diego Rayes, Guillermo Spitzmaul, Steven M. Sine, and Cecilia Bouzat

Instituto de Investigaciones Bioquimicas, Universidad Nacional del Sur–Consejo Nacional de Investigaciones Científicas y Técnicas, Bahia Blanca, Argentina (D.R., G.S., C.B.); and Receptor Biology Laboratory, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota (S.M.S.)

The receptor chimera {alpha}7–5HT3A has served as a prototype for understanding the pharmacology of {alpha}7 neuronal nicotinic receptors, yet its low single channel conductance has prevented studies of the activation kinetics of single receptor channels. In this study, we show that introducing mutations in the M3–M4 cytoplasmic linker of the chimera alters neither the apparent affinity for the agonist nor the EC50 but increases the amplitude of agonist-evoked single channel currents to enable kinetic analysis. Channel events appear as single brief openings flanked by long closings or as bursts of several openings in quick succession. Both the open and closed time distributions are described as the sum of multiple exponential components, but these do not change over a wide range of acetylcholine (ACh), nicotine, or choline concentrations. Bursts elicited by a saturating concentration of ACh contain brief and long openings and closings, and a cyclic scheme containing two open and two closed states is found to adequately describe the data. The analysis indicates that once fully occupied, the receptor opens rapidly and efficiently, and closes and reopens several times before it desensitizes. Channel closing and desensitization occur at similar rates and account for the invariant open and closed time distributions.


Received June 1, 2005; accepted August 23, 2005

Address correspondence to: Cecilia Bouzat, Instituto de Investigaciones Bioquímicas, Camino La Carrindanga Km 7, 8000 Bahía Blanca, Argentina. E-mail: inbouzat{at}criba.edu.ar




This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Bouzat, M. Bartos, J. Corradi, and S. M. Sine
The Interface between Extracellular and Transmembrane Domains of Homomeric Cys-Loop Receptors Governs Open-Channel Lifetime and Rate of Desensitization
J. Neurosci., July 30, 2008; 28(31): 7808 - 7819.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Rayes, M. Flamini, G. Hernando, and C. Bouzat
Activation of Single Nicotinic Receptor Channels from Caenorhabditis elegans Muscle
Mol. Pharmacol., May 1, 2007; 71(5): 1407 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Bartos, D. Rayes, and C. Bouzat
Molecular Determinants of Pyrantel Selectivity in Nicotinic Receptors
Mol. Pharmacol., October 1, 2006; 70(4): 1307 - 1318.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics